Growth looks exciting from a distance, but in outpatient surgery, it can become expensive very quickly when the basics are not stable. In 2026, ASC consulting is increasingly focused on helping leaders test the strength of their operating foundation before they add rooms, specialities, equipment, or case volume. A surgery centre that expands without clear visibility into workflow, staffing and risk management usually does not create smooth growth. It creates larger versions of existing problems.[1][2]
FDA says real-world data now include electronic health records, claims data and digital health technologies, which reflect how much modern healthcare depends on connected information and fit-for-purpose data.[1]
That same principle applies to an ASC. If the underlying data and processes are weak, growth decisions become harder to trust.
A weak foundation often hides behind a busy schedule. Cases still happen. Revenue still comes in. Staff still find ways to make the day work. But a centre can be active and still be fragile. Risk management research in outpatient surgery describes organisational risk in many steps of the patient journey, including patient selection, preoperative assessment, surgery and follow-up.[2]
When those steps are not tightly coordinated, new growth tends to amplify friction, not solve it. Growth fails most often when leaders mistake current motion for real readiness.
What consulting can reveal before expansion begins?
Consulting is most useful before expansion, when it helps leaders see the operation as it actually works, not as they hope it works. That means looking at throughput, staffing patterns, supply dependencies, hand-offs, documentation quality, and the centre’s ability to monitor meaningful indicators over time.[3]
A good growth review should identify where delay, duplication, or uncertainty already exist before new complexity arrives. In practical terms, that is how leaders avoid paying for a larger footprint that still runs on unclear processes.
Quality indicator research in ambulatory surgery supports this approach. Reviews emphasise that outpatient facilities should monitor quality and safety using relevant indicators not relying on volume alone as a sign of success.[3]
That matters because volume can mask poor readiness. A centre may appear productive while cancellations, hand-off problems, inconsistent documentation, or avoidable delays quietly erode performance. Consulting can reveal whether those issues are isolated events or signs that the operating model needs redesign before expansion begins.
How does feasibility thinking protect time and energy?
Feasibility is often misunderstood as a financing exercise. In reality, feasibility is a discipline of asking whether the centre’s clinical, operational and compliance realities support the growth being proposed. It protects time by preventing leadership from chasing an attractive idea before the centre knows whether the workflow can support it. It protects capital by identifying whether the centre is about to buy technology, build space, or launch services that its current model cannot absorb. It protects energy by reducing the emotional cost of starting initiatives that later stall.
This matters more now because medtech companies and payers increasingly see ASCs as growth settings. MedTech Dive reported in January 2026 that Medtronic and Mindray extended their collaboration to bring patient monitoring technology into ambulatory surgery centres, explicitly citing procedure migration from hospitals to ASCs and the need to adapt technology and procurement for more sites of care.[4] The same publication reported that ASCs received $7.5 billion for treating 3.4 million fee-for-service Medicare beneficiaries in 2024.[4]
Those numbers help explain why expansion conversations are accelerating. But external momentum does not eliminate the need for internal discipline. A quotable truth for leaders is this: growth opportunity is not the same thing as growth readiness.
Why does the right operational model matter before new services launch?
A new service line changes more than the schedule. It changes staffing needs, case preparation, discharge planning, equipment requirements, documentation expectations, and risk exposure. That is why the right operational model matters before any growth move becomes real. If the model does not fit the actual service mix, the centre may add revenue potential while reducing predictability.
This is especially important as more complex procedures continue to move toward outpatient settings. MedTech Dive reported that CMS finalised coverage of cardiac catheter ablation in ASCs effective January 1, 2026, a policy change tied to stronger safety data, better workflows, and improved technology.[5]
That decision is a useful signal for ASC leaders. When outpatient care expands into more complex territory, the need for the right operational model becomes greater, not smaller. New services should fit the centre’s workflow, training level, monitoring ability, and quality oversight. Otherwise, the launch can strain the system faster than leadership expects.
A second industry signal comes from orthopaedics. MedTech Dive reported in February 2025 that Zimmer forecast 40% to 60% of all orthopaedic cases could move to ASCs in three to five years, and said nearly 20% of its US sales already came from ASCs.[6]
That forecast does not guarantee the same pattern for every centre, but it does underscore how site-of-care migration is reshaping planning. Leaders should treat that change as a reason to sharpen their operating model before expansion, not after.
How does compliance planning support smarter growth?
Compliance planning is often treated as a late-stage item in growth. That is a mistake. In reality, compliance planning helps define whether growth will feel controlled or chaotic. A centre that adds a new service, new equipment, or new staffing model without aligning policies, training and task ownership usually ends up managing uncertainty in parallel with expansion. That drains time and confidence.
Risk management literature on outpatient surgery reinforces that the pathway requires formal organisation in multiple stages of care and that patient safety depends on coordinated systems, not isolated fixes.[2]
FDA’s current real-world evidence materials also emphasise fit-for-purpose data and the value of reliable records for oversight and decision-making.[1]
Together, those ideas support a simple management lesson. Compliance is not a box to check after growth is approved. It is part of the structure that allows growth to happen safely and sustainably. When compliance planning is integrated early, leaders are more likely to know which training is current, which documentation is complete, which responsibilities are assigned, and which risks are visible before they become urgent.
What leaders should review before adding complexity to the centre?
Before adding complexity, leaders should review more than the business case. They should review whether their current operation produces trustworthy data, predictable flow, and meaningful performance indicators. They should review whether staffing patterns reduce unnecessary hand-offs and whether communication in the day is clear enough to support a busier, more varied caseload. They should also review patient selection and risk stratification practices, because expansion does not remove the need for disciplined case appropriateness.
Research on preoperative screening in ambulatory surgery emphasises the importance of multidisciplinary assessment and risk evaluation in the outpatient setting.[7]
Reviews on high-risk ambulatory patients make a similar point by focusing on identifying, stratifying and managing patients appropriately in outpatient environments.[8]
These findings matter for growth decisions because a centre that stretches beyond its patient selection discipline can create safety and operational problems at the same time. Adding complexity should never mean lowering the threshold for readiness.
Why do scalable systems matter more than quick fixes?
Quick fixes can stabilise a bad week. They rarely support a bigger future. Scalable systems matter because they continue to work when the centre gets busier, when new staff members join, when new services launch, and when leaders can not personally monitor every detail of the day. A scalable system produces consistent results without depending on constant rescue from a few experienced people.
This is where digital visibility starts to matter. FDA’s current descriptions of real-world data and real-world evidence show how much value in modern healthcare depends on routinely collected, usable information from connected systems.[1]
In an ASC, the practical version of that idea is straightforward. Leaders need systems that make delays and drift visible early enough to correct them. They need more than software adoption. They need decision-quality information. A third memorable statement belongs here. Technology does not make a centre scalable by itself. Clear processes plus usable data make a centre scalable.
How does experienced guidance help growth feel controlled instead of risky?
Experienced guidance helps growth feel controlled because it gives leaders an order of operations. Instead of trying to solve everything at once, the centre can identify what must be standardised, what must be redesigned, and what should be measured first. Quality indicators, workflow reliability, staffing logic, and compliance visibility become part of one plan not separate projects.[2][3]
That makes growth feel less like a gamble and more like a managed transition.
As Tina DiMarino says, ‘Custom Surgical Partners approaches ambulatory surgery centre consulting as a way to align compliance and operational planning before expansion so growth feels structured instead of reactive.’
That kind of guidance is especially useful in a market where outside pressure to grow is rising. Device makers and health systems increasingly treat ASCs as sites of care.[4][5][6]
But external enthusiasm can push centres to move too quickly. Experienced guidance helps leadership distinguish between a market opening and a centre-specific opportunity. Those are not always the same thing.
What sustainable expansion looks like in 2026?
Sustainable expansion in 2026 looks measured and connected. It does not begin with the assumption that growth is automatically good. It begins with the question of whether the centre’s foundation is strong enough to support more complexity without losing reliability. It uses feasibility thinking to protect capital and time. It treats compliance planning as an early design function, not a late administrative step. It reviews patient selection, staffing logic and data quality before the growth move becomes expensive.[1][2][7][8]
The strongest centres will keep expanding outpatient ability, but they will do so with more discipline, not less. They will understand that growth succeeds when the system is ready to absorb it. The closing takeaway is simple. Sustainable expansion is not about adding more as quickly as possible. It is about building a centre that can grow without losing control.
References:
[1] US Food and Drug Administration, Real-World Evidence, April 2, 2026
[2] Theissen A., Slim K., Deleuze A., Beaussier M., Risk management in outpatient surgery, 2019
[3] Glowka L., Quality indicators and outcomes in ambulatory surgery, 2023
[4] MedTech Dive, Medtronic targets ASCs with extended Mindray collaboration, January 27, 2026
[5] MedTech Dive, Intuitive pushes into cardiac robotic surgery and ASCs, January 23, 2026
[6] MedTech Dive, Zimmer touts ASC opportunity with Paragon 28 purchase, February 6, 2025
[7] Gupta A., Preoperative screening and risk assessment in the ambulatory surgical patient, 2009
[8] Rajan N., The high-risk patient for ambulatory surgery, 2020
